

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.06473627 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.06473627 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.00926245 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.17500501 |
| 5 | leukocyte aggregation (GO:0070486) | 5.12411322 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 5.09289006 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84651696 |
| 8 | valine metabolic process (GO:0006573) | 4.72575861 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.55021511 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.49421810 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.47729709 |
| 12 | detection of bacterium (GO:0016045) | 4.34990006 |
| 13 | tolerance induction (GO:0002507) | 4.29377831 |
| 14 | T cell selection (GO:0045058) | 4.22956950 |
| 15 | detection of other organism (GO:0098543) | 4.18203044 |
| 16 | positive T cell selection (GO:0043368) | 4.10167737 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.99315793 |
| 18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.99048315 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98972569 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 3.79156377 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77987330 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.77987330 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77987330 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77987330 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77987330 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.77987330 |
| 27 | viral transcription (GO:0019083) | 3.76187194 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.75539434 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.75095464 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.71333410 |
| 31 | response to interleukin-15 (GO:0070672) | 3.67266533 |
| 32 | T cell migration (GO:0072678) | 3.67217929 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.62411715 |
| 34 | translational termination (GO:0006415) | 3.61804476 |
| 35 | regulation of tolerance induction (GO:0002643) | 3.61528288 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 3.51984453 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.51367602 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49532654 |
| 39 | Peyers patch development (GO:0048541) | 3.48395178 |
| 40 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.48395178 |
| 41 | DNA deamination (GO:0045006) | 3.42921747 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.36488749 |
| 43 | neutrophil activation (GO:0042119) | 3.33851372 |
| 44 | positive regulation of tolerance induction (GO:0002645) | 3.33118740 |
| 45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.32290279 |
| 46 | negative T cell selection (GO:0043383) | 3.30994044 |
| 47 | response to peptidoglycan (GO:0032494) | 3.27211920 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.26286929 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.25838532 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.25150819 |
| 51 | translational elongation (GO:0006414) | 3.23688640 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.22783333 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22395054 |
| 54 | regulation of B cell differentiation (GO:0045577) | 3.20329921 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 3.18725725 |
| 56 | negative regulation of innate immune response (GO:0045824) | 3.17901900 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.16020914 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13531452 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.13472422 |
| 60 | activated T cell proliferation (GO:0050798) | 3.12848159 |
| 61 | respiratory burst (GO:0045730) | 3.10097494 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08056870 |
| 63 | cotranslational protein targeting to membrane (GO:0006613) | 3.06567171 |
| 64 | definitive hemopoiesis (GO:0060216) | 3.06270388 |
| 65 | protein targeting to ER (GO:0045047) | 3.05491846 |
| 66 | signal complex assembly (GO:0007172) | 3.03841825 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.03820029 |
| 68 | granulocyte activation (GO:0036230) | 3.03296141 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.02672222 |
| 70 | leukocyte degranulation (GO:0043299) | 3.01816978 |
| 71 | detection of external biotic stimulus (GO:0098581) | 3.00310350 |
| 72 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.97575412 |
| 73 | maturation of SSU-rRNA (GO:0030490) | 2.96580043 |
| 74 | ribosomal small subunit biogenesis (GO:0042274) | 2.96136643 |
| 75 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.95215615 |
| 76 | protein localization to endoplasmic reticulum (GO:0070972) | 2.94733524 |
| 77 | interferon-gamma secretion (GO:0072643) | 2.94078108 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93789474 |
| 79 | positive regulation of immune response to tumor cell (GO:0002839) | 2.91088771 |
| 80 | regulation of immune response to tumor cell (GO:0002837) | 2.91088771 |
| 81 | regulation of response to tumor cell (GO:0002834) | 2.91088771 |
| 82 | positive regulation of response to tumor cell (GO:0002836) | 2.91088771 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89119527 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88708532 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88690965 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88521545 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.88244395 |
| 88 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.87636608 |
| 89 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.87553939 |
| 90 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.87553939 |
| 91 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86899419 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.85776934 |
| 93 | oxaloacetate metabolic process (GO:0006107) | 2.84995384 |
| 94 | negative regulation of interleukin-6 production (GO:0032715) | 2.84385645 |
| 95 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83009936 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 2.82898987 |
| 97 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82154063 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81875248 |
| 99 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80482422 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80037874 |
| 101 | T cell homeostasis (GO:0043029) | 2.79611079 |
| 102 | response to interferon-beta (GO:0035456) | 2.79544212 |
| 103 | viral life cycle (GO:0019058) | 2.79469257 |
| 104 | regulation of response to interferon-gamma (GO:0060330) | 2.79377283 |
| 105 | negative regulation of cell killing (GO:0031342) | 2.78959433 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.78959433 |
| 107 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78686564 |
| 108 | positive regulation of interleukin-17 production (GO:0032740) | 2.78350821 |
| 109 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.76671338 |
| 110 | B cell mediated immunity (GO:0019724) | 2.75936203 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 2.75798717 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.75078084 |
| 113 | mannose metabolic process (GO:0006013) | 2.74814823 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74653362 |
| 115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.74418116 |
| 116 | cellular extravasation (GO:0045123) | 2.73990489 |
| 117 | thymic T cell selection (GO:0045061) | 2.73832674 |
| 118 | germinal center formation (GO:0002467) | 2.73716105 |
| 119 | lymphocyte migration (GO:0072676) | 2.73602346 |
| 120 | mast cell activation (GO:0045576) | 2.72971504 |
| 121 | regulation of defense response to virus by virus (GO:0050690) | 2.72709302 |
| 122 | regulation of natural killer cell differentiation (GO:0032823) | 2.72149860 |
| 123 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.70746061 |
| 124 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.70746061 |
| 125 | lymph node development (GO:0048535) | 2.70037779 |
| 126 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.68532696 |
| 127 | response to type I interferon (GO:0034340) | 2.68104866 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.67009334 |
| 129 | type I interferon signaling pathway (GO:0060337) | 2.67009334 |
| 130 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.65857695 |
| 131 | urate metabolic process (GO:0046415) | 2.65378901 |
| 132 | megakaryocyte development (GO:0035855) | 2.65043647 |
| 133 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.64943724 |
| 134 | L-phenylalanine metabolic process (GO:0006558) | 2.64784562 |
| 135 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.64784562 |
| 136 | indole-containing compound catabolic process (GO:0042436) | 2.63763541 |
| 137 | indolalkylamine catabolic process (GO:0046218) | 2.63763541 |
| 138 | tryptophan catabolic process (GO:0006569) | 2.63763541 |
| 139 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.62489537 |
| 140 | 2-oxoglutarate metabolic process (GO:0006103) | 2.60275919 |
| 141 | cellular protein complex disassembly (GO:0043624) | 2.60217674 |
| 142 | aromatic amino acid family catabolic process (GO:0009074) | 2.59846607 |
| 143 | interferon-gamma production (GO:0032609) | 2.58665612 |
| 144 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.57394994 |
| 145 | translational initiation (GO:0006413) | 2.56283540 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.53052821 |
| 147 | L-phenylalanine catabolic process (GO:0006559) | 2.53052821 |
| 148 | branched-chain amino acid metabolic process (GO:0009081) | 2.52145922 |
| 149 | T cell receptor signaling pathway (GO:0050852) | 2.51921251 |
| 150 | drug transport (GO:0015893) | 2.50027367 |
| 151 | glyoxylate metabolic process (GO:0046487) | 2.49083060 |
| 152 | tryptophan metabolic process (GO:0006568) | 2.49022741 |
| 153 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.48935418 |
| 154 | positive regulation of humoral immune response (GO:0002922) | 2.47931702 |
| 155 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.47126756 |
| 156 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.45851285 |
| 157 | natural killer cell differentiation (GO:0001779) | 2.44876688 |
| 158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.42866693 |
| 159 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39818845 |
| 160 | drug transmembrane transport (GO:0006855) | 2.39312484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89208944 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.61900425 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.14828895 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05683941 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00438927 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78626870 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.77722013 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64899451 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.62644649 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62548594 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58816183 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53467966 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.43188858 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.42129919 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25683967 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24639870 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23591655 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19556793 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18796760 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15201760 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13402412 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11607268 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.11547300 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09766782 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09522091 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05677881 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00388380 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 1.97160113 |
| 29 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96283934 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.94508410 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93057953 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88067388 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 1.87056157 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80845465 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78920088 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75633207 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73700932 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69138867 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68487171 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68486063 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.68138699 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66879927 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63232539 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.61820009 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61577228 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59102202 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.59035892 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.55637790 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54775480 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54139440 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.54119316 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.52433915 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49422844 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49035341 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48549024 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47753847 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47195965 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46950614 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46273970 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45617049 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45410995 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44231518 |
| 63 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43991192 |
| 64 | * MAF_26560356_Chip-Seq_TH2_Human | 1.43870367 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43290732 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42213352 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39950332 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38646279 |
| 69 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37069137 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36668811 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36432028 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36193732 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35151667 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34102838 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34073580 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33489204 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33271890 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32902633 |
| 79 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32542175 |
| 80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32511708 |
| 81 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31869742 |
| 82 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31641572 |
| 83 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31001678 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30736502 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30713353 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30586074 |
| 87 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29030434 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28982527 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28673515 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28442686 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27508193 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26274239 |
| 93 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25901882 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22437306 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21757826 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21366050 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21364094 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18180232 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17144180 |
| 100 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15638633 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14956541 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14488329 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14446002 |
| 104 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13240752 |
| 105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12726006 |
| 106 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12507476 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12106811 |
| 108 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10528107 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10318013 |
| 110 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10155474 |
| 111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08757522 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08392128 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08311423 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07709754 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06348013 |
| 116 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05593882 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05514636 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05176003 |
| 119 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04862502 |
| 120 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04802230 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04525413 |
| 122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02574908 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02339820 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 1.01825178 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01660688 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99550327 |
| 127 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99342939 |
| 128 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.99026282 |
| 129 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98539959 |
| 130 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97503074 |
| 131 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.97432923 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97069656 |
| 133 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97023574 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96753473 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96237975 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95081621 |
| 137 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94444230 |
| 138 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94092301 |
| 139 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93392887 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92671953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.11353423 |
| 2 | MP0003763_abnormal_thymus_physiology | 2.97235510 |
| 3 | MP0005671_abnormal_response_to | 2.97101972 |
| 4 | MP0003303_peritoneal_inflammation | 2.96762769 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.93517759 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.93479417 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.90740577 |
| 8 | MP0000685_abnormal_immune_system | 2.75743367 |
| 9 | MP0005365_abnormal_bile_salt | 2.64957312 |
| 10 | MP0009785_altered_susceptibility_to | 2.55295484 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.32551584 |
| 12 | MP0001800_abnormal_humoral_immune | 2.28077253 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.23559694 |
| 14 | MP0001873_stomach_inflammation | 2.17756504 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.15398099 |
| 16 | MP0002398_abnormal_bone_marrow | 2.09847139 |
| 17 | MP0005025_abnormal_response_to | 2.06727128 |
| 18 | MP0003724_increased_susceptibility_to | 2.01509890 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.98200941 |
| 20 | * MP0002723_abnormal_immune_serum | 1.97764498 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.96240083 |
| 22 | * MP0001819_abnormal_immune_cell | 1.94747066 |
| 23 | MP0000689_abnormal_spleen_morphology | 1.94027431 |
| 24 | MP0005387_immune_system_phenotype | 1.93066981 |
| 25 | MP0001790_abnormal_immune_system | 1.93066981 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.91928983 |
| 27 | * MP0002452_abnormal_antigen_presenting | 1.88641021 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.88167582 |
| 29 | MP0002722_abnormal_immune_system | 1.85735545 |
| 30 | MP0000716_abnormal_immune_system | 1.81751974 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.79538942 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.79538023 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.77590800 |
| 34 | MP0008260_abnormal_autophagy | 1.74188399 |
| 35 | MP0002006_tumorigenesis | 1.72695805 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.71613262 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.71613262 |
| 38 | MP0001853_heart_inflammation | 1.68745495 |
| 39 | * MP0010155_abnormal_intestine_physiology | 1.68005525 |
| 40 | MP0003436_decreased_susceptibility_to | 1.66705279 |
| 41 | MP0002429_abnormal_blood_cell | 1.66187081 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.65938781 |
| 43 | MP0003866_abnormal_defecation | 1.63270485 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.60965556 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.60114554 |
| 46 | MP0009840_abnormal_foam_cell | 1.55607503 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.53522110 |
| 48 | MP0002405_respiratory_system_inflammati | 1.53448661 |
| 49 | * MP0009333_abnormal_splenocyte_physiolog | 1.51154041 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.49699679 |
| 51 | MP0002419_abnormal_innate_immunity | 1.48496634 |
| 52 | * MP0001845_abnormal_inflammatory_respons | 1.45661857 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.43688253 |
| 54 | MP0008469_abnormal_protein_level | 1.41443423 |
| 55 | MP0000490_abnormal_crypts_of | 1.40469016 |
| 56 | MP0004381_abnormal_hair_follicle | 1.39358072 |
| 57 | MP0004947_skin_inflammation | 1.37267179 |
| 58 | MP0003252_abnormal_bile_duct | 1.37039747 |
| 59 | MP0003693_abnormal_embryo_hatching | 1.36800210 |
| 60 | MP0005451_abnormal_body_composition | 1.35728271 |
| 61 | MP0006082_CNS_inflammation | 1.34712124 |
| 62 | MP0002254_reproductive_system_inflammat | 1.33794648 |
| 63 | MP0001851_eye_inflammation | 1.33026410 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.31811837 |
| 65 | MP0000609_abnormal_liver_physiology | 1.31266260 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.31084799 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.29807333 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.29342039 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.24704654 |
| 70 | MP0003186_abnormal_redox_activity | 1.23299329 |
| 71 | MP0005332_abnormal_amino_acid | 1.22402833 |
| 72 | MP0009764_decreased_sensitivity_to | 1.20555807 |
| 73 | MP0001764_abnormal_homeostasis | 1.18207495 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.18114613 |
| 75 | MP0004147_increased_porphyrin_level | 1.18113643 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.16577620 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.16042446 |
| 78 | MP0001663_abnormal_digestive_system | 1.14590259 |
| 79 | MP0002933_joint_inflammation | 1.12912002 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.09695017 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.07981825 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 1.07879632 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 1.06230168 |
| 84 | MP0000598_abnormal_liver_morphology | 1.05215468 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 1.04752687 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 1.04387851 |
| 87 | MP0003828_pulmonary_edema | 1.04028606 |
| 88 | MP0009278_abnormal_bone_marrow | 1.02754874 |
| 89 | MP0009763_increased_sensitivity_to | 1.02350537 |
| 90 | MP0008058_abnormal_DNA_repair | 1.00483455 |
| 91 | MP0005166_decreased_susceptibility_to | 0.99461462 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98574731 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.98148389 |
| 94 | MP0005083_abnormal_biliary_tract | 0.98059336 |
| 95 | MP0003075_altered_response_to | 0.97684334 |
| 96 | MP0002132_abnormal_respiratory_system | 0.94272766 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.94078826 |
| 98 | MP0000858_altered_metastatic_potential | 0.93900927 |
| 99 | MP0010094_abnormal_chromosome_stability | 0.93319693 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.92731292 |
| 101 | MP0005310_abnormal_salivary_gland | 0.92479626 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.91504759 |
| 103 | MP0008057_abnormal_DNA_replication | 0.90300802 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.89873657 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.89252380 |
| 106 | MP0003868_abnormal_feces_composition | 0.88019965 |
| 107 | MP0003077_abnormal_cell_cycle | 0.86994923 |
| 108 | MP0005390_skeleton_phenotype | 0.85952259 |
| 109 | MP0009379_abnormal_foot_pigmentation | 0.83672985 |
| 110 | MP0003448_altered_tumor_morphology | 0.82818274 |
| 111 | MP0004883_abnormal_blood_vessel | 0.79484631 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.79048950 |
| 113 | MP0004510_myositis | 0.75773370 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.75155831 |
| 115 | MP0008004_abnormal_stomach_pH | 0.74374124 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.74158454 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.73854958 |
| 118 | MP0002928_abnormal_bile_duct | 0.72380719 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.72212366 |
| 120 | MP0008007_abnormal_cellular_replicative | 0.72094508 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.72033231 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.71898289 |
| 123 | MP0000249_abnormal_blood_vessel | 0.66439927 |
| 124 | MP0000678_abnormal_parathyroid_gland | 0.63861549 |
| 125 | MP0003795_abnormal_bone_structure | 0.62115566 |
| 126 | MP0005164_abnormal_response_to | 0.60567515 |
| 127 | MP0002009_preneoplasia | 0.60409318 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.57808408 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.56323872 |
| 130 | MP0008874_decreased_physiological_sensi | 0.55590952 |
| 131 | MP0000343_altered_response_to | 0.54435895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.79266688 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.62462840 |
| 3 | IgM deficiency (HP:0002850) | 4.59072355 |
| 4 | Orchitis (HP:0100796) | 4.54583320 |
| 5 | Stomatitis (HP:0010280) | 4.26783172 |
| 6 | Thrombocytosis (HP:0001894) | 4.26144755 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.23104759 |
| 8 | Optic neuritis (HP:0100653) | 4.23104759 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.87532580 |
| 10 | Obstructive lung disease (HP:0006536) | 3.84341456 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.84341456 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82973427 |
| 13 | Chronic otitis media (HP:0000389) | 3.79868067 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64596286 |
| 15 | T lymphocytopenia (HP:0005403) | 3.55525136 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.55396326 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.54976494 |
| 18 | Increased IgE level (HP:0003212) | 3.51936607 |
| 19 | Abnormality of T cells (HP:0002843) | 3.41882465 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.40717512 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.35195962 |
| 22 | Petechiae (HP:0000967) | 3.24287403 |
| 23 | Vasculitis (HP:0002633) | 3.15212618 |
| 24 | Myositis (HP:0100614) | 3.13355774 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.06207779 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.05419112 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.03231711 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.03231711 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.01864782 |
| 30 | Epistaxis (HP:0000421) | 2.87633624 |
| 31 | Generalized aminoaciduria (HP:0002909) | 2.85611065 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 2.85480570 |
| 33 | Nasal polyposis (HP:0100582) | 2.83979740 |
| 34 | Granulocytopenia (HP:0001913) | 2.83610464 |
| 35 | Cellulitis (HP:0100658) | 2.83350768 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.82178239 |
| 37 | IgG deficiency (HP:0004315) | 2.82134284 |
| 38 | Reticulocytopenia (HP:0001896) | 2.81555414 |
| 39 | Urticaria (HP:0001025) | 2.81505874 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.76478248 |
| 41 | Chest pain (HP:0100749) | 2.76217499 |
| 42 | Combined immunodeficiency (HP:0005387) | 2.75689608 |
| 43 | Gingivitis (HP:0000230) | 2.75161759 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.75061109 |
| 45 | Pustule (HP:0200039) | 2.72645620 |
| 46 | Hypochromic anemia (HP:0001931) | 2.68449787 |
| 47 | Aplastic anemia (HP:0001915) | 2.68152577 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.64725257 |
| 49 | Increased IgM level (HP:0003496) | 2.62131831 |
| 50 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61711407 |
| 51 | B lymphocytopenia (HP:0010976) | 2.57486127 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.57486127 |
| 53 | Lymphopenia (HP:0001888) | 2.57479832 |
| 54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56563086 |
| 55 | Hemoptysis (HP:0002105) | 2.55502761 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.55498574 |
| 57 | Poikiloderma (HP:0001029) | 2.54441304 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.54361120 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.54241682 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.51028589 |
| 61 | Thyroiditis (HP:0100646) | 2.50673424 |
| 62 | Anorexia (HP:0002039) | 2.50082931 |
| 63 | Leukocytosis (HP:0001974) | 2.50003838 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49957883 |
| 65 | Abnormal platelet function (HP:0011869) | 2.48732707 |
| 66 | Impaired platelet aggregation (HP:0003540) | 2.48732707 |
| 67 | Chronic diarrhea (HP:0002028) | 2.48381928 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48032382 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.46513652 |
| 70 | Increased serum ferritin (HP:0003281) | 2.46367118 |
| 71 | IgA deficiency (HP:0002720) | 2.45334349 |
| 72 | Recurrent viral infections (HP:0004429) | 2.44607681 |
| 73 | Seborrheic dermatitis (HP:0001051) | 2.43738896 |
| 74 | Pulmonary embolism (HP:0002204) | 2.43675642 |
| 75 | Gingival bleeding (HP:0000225) | 2.42130492 |
| 76 | Intrahepatic cholestasis (HP:0001406) | 2.41976628 |
| 77 | Verrucae (HP:0200043) | 2.40079054 |
| 78 | Papilloma (HP:0012740) | 2.40079054 |
| 79 | Abnormality of the fingertips (HP:0001211) | 2.36364960 |
| 80 | Entropion (HP:0000621) | 2.35056139 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31109461 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31109461 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.30014860 |
| 84 | Microcytic anemia (HP:0001935) | 2.29373001 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.26834701 |
| 86 | Joint swelling (HP:0001386) | 2.26208064 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.25633145 |
| 88 | Bronchitis (HP:0012387) | 2.25000289 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.24720369 |
| 90 | Episodic fever (HP:0001954) | 2.22504851 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.22135255 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.21651083 |
| 93 | Papilledema (HP:0001085) | 2.20885257 |
| 94 | Recurrent sinusitis (HP:0011108) | 2.20633216 |
| 95 | Hypobetalipoproteinemia (HP:0003563) | 2.19228564 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.18843778 |
| 97 | Encephalitis (HP:0002383) | 2.18750224 |
| 98 | Amaurosis fugax (HP:0100576) | 2.16631571 |
| 99 | Basal cell carcinoma (HP:0002671) | 2.16575979 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 2.15141895 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15132806 |
| 102 | Increased muscle lipid content (HP:0009058) | 2.14940627 |
| 103 | Gout (HP:0001997) | 2.14618848 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.14418386 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.13836062 |
| 106 | Joint hemorrhage (HP:0005261) | 2.13206038 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.12903697 |
| 108 | Hyperammonemia (HP:0001987) | 2.12542647 |
| 109 | Hypoglycemic coma (HP:0001325) | 2.12321511 |
| 110 | Thrombophlebitis (HP:0004418) | 2.11792424 |
| 111 | Hyperglycinuria (HP:0003108) | 2.11573039 |
| 112 | Agammaglobulinemia (HP:0004432) | 2.10734189 |
| 113 | Abnormality of eosinophils (HP:0001879) | 2.10066228 |
| 114 | Amyloidosis (HP:0011034) | 2.10034446 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10007515 |
| 116 | Lymphoma (HP:0002665) | 2.09953152 |
| 117 | Recurrent abscess formation (HP:0002722) | 2.09685809 |
| 118 | Xanthomatosis (HP:0000991) | 2.08087673 |
| 119 | Hypertensive crisis (HP:0100735) | 2.07832239 |
| 120 | Loss of speech (HP:0002371) | 2.07568333 |
| 121 | Hyperlipoproteinemia (HP:0010980) | 2.07321096 |
| 122 | Meningitis (HP:0001287) | 2.06501363 |
| 123 | Abnormal platelet volume (HP:0011876) | 2.05773348 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 2.05133059 |
| 125 | Acne (HP:0001061) | 2.04978633 |
| 126 | Macrocytic anemia (HP:0001972) | 2.04450999 |
| 127 | Purpura (HP:0000979) | 2.03540235 |
| 128 | Pancytopenia (HP:0001876) | 2.02701506 |
| 129 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02621888 |
| 130 | Abnormality of the pleura (HP:0002103) | 2.01573819 |
| 131 | Increased cerebral lipofuscin (HP:0011813) | 2.01377003 |
| 132 | Colitis (HP:0002583) | 1.99735613 |
| 133 | Gangrene (HP:0100758) | 1.99201273 |
| 134 | Eosinophilia (HP:0001880) | 1.98676673 |
| 135 | Osteomyelitis (HP:0002754) | 1.98467808 |
| 136 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.98111595 |
| 137 | Skin ulcer (HP:0200042) | 1.96828289 |
| 138 | Autoimmune thrombocytopenia (HP:0001973) | 1.96423872 |
| 139 | Sepsis (HP:0100806) | 1.96400602 |
| 140 | Polygenic inheritance (HP:0010982) | 1.96333431 |
| 141 | Glomerulopathy (HP:0100820) | 1.95006290 |
| 142 | Menorrhagia (HP:0000132) | 1.94992272 |
| 143 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94362750 |
| 144 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94362750 |
| 145 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94362750 |
| 146 | Recurrent skin infections (HP:0001581) | 1.93918462 |
| 147 | Gastrointestinal stroma tumor (HP:0100723) | 1.92838886 |
| 148 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92786178 |
| 149 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92207233 |
| 150 | Deep venous thrombosis (HP:0002625) | 1.90973101 |
| 151 | Systemic lupus erythematosus (HP:0002725) | 1.89943757 |
| 152 | Ketosis (HP:0001946) | 1.89491870 |
| 153 | Acute hepatic failure (HP:0006554) | 1.89287142 |
| 154 | Arterial thrombosis (HP:0004420) | 1.89007581 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.88895942 |
| 156 | Hemorrhage of the eye (HP:0011885) | 1.88862609 |
| 157 | Eczematoid dermatitis (HP:0000976) | 1.88105568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.51014782 |
| 2 | TXK | 3.18419192 |
| 3 | JAK3 | 3.17863004 |
| 4 | NME2 | 3.14480655 |
| 5 | RIPK4 | 3.09050678 |
| 6 | KIT | 2.81338679 |
| 7 | PRPF4B | 2.78436975 |
| 8 | KDR | 2.58762574 |
| 9 | ZAP70 | 2.55943664 |
| 10 | FGFR4 | 2.46244895 |
| 11 | BTK | 2.36173645 |
| 12 | BCKDK | 2.26639238 |
| 13 | MAP2K3 | 2.12138320 |
| 14 | TEC | 2.08259234 |
| 15 | TGFBR1 | 2.07246771 |
| 16 | FLT3 | 2.04683069 |
| 17 | IKBKE | 2.03411086 |
| 18 | TYK2 | 1.97654881 |
| 19 | TGFBR2 | 1.93092625 |
| 20 | EEF2K | 1.90016843 |
| 21 | EPHB1 | 1.81425985 |
| 22 | SIK3 | 1.72176645 |
| 23 | STK16 | 1.69080653 |
| 24 | SYK | 1.68885952 |
| 25 | SIK1 | 1.65927862 |
| 26 | TBK1 | 1.64383850 |
| 27 | BLK | 1.62473628 |
| 28 | ITK | 1.61008869 |
| 29 | TIE1 | 1.60150280 |
| 30 | NLK | 1.59772109 |
| 31 | TAOK1 | 1.59047193 |
| 32 | STK10 | 1.56584338 |
| 33 | SMG1 | 1.47173558 |
| 34 | CSF1R | 1.45444721 |
| 35 | ACVR1B | 1.42329220 |
| 36 | GRK6 | 1.41962897 |
| 37 | MAP3K14 | 1.41840765 |
| 38 | LCK | 1.33834958 |
| 39 | JAK1 | 1.33578390 |
| 40 | RIPK1 | 1.28272865 |
| 41 | IKBKB | 1.22902001 |
| 42 | MAP2K6 | 1.22408141 |
| 43 | ERN1 | 1.21381571 |
| 44 | WEE1 | 1.20393048 |
| 45 | PRKD2 | 1.19111361 |
| 46 | PASK | 1.16136139 |
| 47 | TAOK3 | 1.12317457 |
| 48 | LRRK2 | 1.12225391 |
| 49 | PIM1 | 1.11406310 |
| 50 | TAOK2 | 1.04651815 |
| 51 | PTK6 | 1.04593317 |
| 52 | RPS6KB2 | 1.04311388 |
| 53 | PKN2 | 1.00930467 |
| 54 | MARK2 | 0.99057996 |
| 55 | LYN | 0.97988804 |
| 56 | IRAK4 | 0.95027819 |
| 57 | MARK3 | 0.93732883 |
| 58 | MAP3K10 | 0.92172505 |
| 59 | MAP3K1 | 0.85782491 |
| 60 | MAP3K3 | 0.84638900 |
| 61 | JAK2 | 0.84350844 |
| 62 | MAPK15 | 0.83297615 |
| 63 | CDK19 | 0.82424506 |
| 64 | SIK2 | 0.82106869 |
| 65 | MAPK11 | 0.82006474 |
| 66 | MST1R | 0.81571578 |
| 67 | TESK1 | 0.81197107 |
| 68 | FGR | 0.79891555 |
| 69 | PDPK1 | 0.79205178 |
| 70 | TESK2 | 0.77989530 |
| 71 | MUSK | 0.77617088 |
| 72 | IRAK3 | 0.77161539 |
| 73 | HCK | 0.76412995 |
| 74 | PIM2 | 0.75383943 |
| 75 | CSK | 0.73792924 |
| 76 | FGFR3 | 0.73416338 |
| 77 | MATK | 0.72800164 |
| 78 | CAMKK1 | 0.72129918 |
| 79 | BMPR2 | 0.71522659 |
| 80 | DYRK3 | 0.71352805 |
| 81 | NEK2 | 0.70952021 |
| 82 | MAP3K12 | 0.69599491 |
| 83 | CDC42BPA | 0.69470783 |
| 84 | CHUK | 0.68920465 |
| 85 | MST4 | 0.67880306 |
| 86 | RPS6KL1 | 0.64651898 |
| 87 | RPS6KC1 | 0.64651898 |
| 88 | DYRK1B | 0.64583333 |
| 89 | MAPK4 | 0.64206589 |
| 90 | MAP3K11 | 0.63234096 |
| 91 | MAPK12 | 0.62261747 |
| 92 | PDK1 | 0.61994045 |
| 93 | FES | 0.61066578 |
| 94 | EIF2AK3 | 0.60107403 |
| 95 | MAPK7 | 0.59325715 |
| 96 | CDK4 | 0.57997112 |
| 97 | MAP3K8 | 0.57744830 |
| 98 | NEK9 | 0.56701169 |
| 99 | MAPKAPK3 | 0.56634150 |
| 100 | FYN | 0.56446966 |
| 101 | BMX | 0.55950819 |
| 102 | TLK1 | 0.53607855 |
| 103 | MAP3K13 | 0.53366172 |
| 104 | TSSK6 | 0.51963765 |
| 105 | VRK1 | 0.50908377 |
| 106 | MAP3K7 | 0.50549261 |
| 107 | EIF2AK1 | 0.50528485 |
| 108 | MAP2K2 | 0.48744723 |
| 109 | INSRR | 0.47459155 |
| 110 | PRKG2 | 0.46097553 |
| 111 | ICK | 0.43981952 |
| 112 | IRAK2 | 0.43442171 |
| 113 | EPHA2 | 0.43057851 |
| 114 | STK38 | 0.42069441 |
| 115 | ADRBK2 | 0.41913472 |
| 116 | HIPK2 | 0.41793712 |
| 117 | CSNK1G3 | 0.40973386 |
| 118 | TRIB3 | 0.40404166 |
| 119 | MAPKAPK2 | 0.38588820 |
| 120 | GRK1 | 0.37942816 |
| 121 | MYLK | 0.37266206 |
| 122 | CDK7 | 0.36731205 |
| 123 | IRAK1 | 0.36473018 |
| 124 | CSNK1G1 | 0.34233280 |
| 125 | PRKD1 | 0.33672773 |
| 126 | CSNK1A1L | 0.33579666 |
| 127 | YES1 | 0.33569537 |
| 128 | ATR | 0.33408951 |
| 129 | AURKB | 0.32949839 |
| 130 | MAPK3 | 0.32203532 |
| 131 | RPS6KA2 | 0.31759456 |
| 132 | TNK2 | 0.31349436 |
| 133 | PAK4 | 0.30814837 |
| 134 | PRKCQ | 0.30444171 |
| 135 | STK4 | 0.29690616 |
| 136 | MAP3K6 | 0.29619030 |
| 137 | RPS6KA6 | 0.28761818 |
| 138 | BUB1 | 0.27444625 |
| 139 | PRKCH | 0.26688229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.72764385 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.88235975 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.82760303 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.25615425 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.16297349 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.09577402 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02889796 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90537897 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83756975 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80371365 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79199327 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76040220 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71939678 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.70125480 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.63251372 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63173463 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59607292 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57859869 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.56622411 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54143505 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53952165 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53441046 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52808583 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52750166 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52050753 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.52044328 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49949486 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.49486867 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49288662 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48999489 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48137122 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47100241 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46408118 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.42209336 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42043024 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.38904453 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35975050 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35302945 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33003308 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31464727 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31334885 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29496621 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27871506 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24206674 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.20662143 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19408457 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19383902 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.19346578 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17514299 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.16792882 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13027180 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.12680698 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11781718 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10925705 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10461208 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08825061 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08624242 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08375479 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06880169 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06467266 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06312879 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06177013 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05854722 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05756261 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04545752 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 1.03869138 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03590724 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02276571 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01417087 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 1.00991857 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00717690 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99753641 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.99685091 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98748316 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.97732686 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94535694 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93824856 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93777979 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.93564680 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93428178 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93402973 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.93373284 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93200951 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.92086406 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91657195 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90477806 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.89992949 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88499411 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87951436 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.84168140 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83282479 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83066698 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82295354 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80219218 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.79060538 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78158954 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77568429 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76530859 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73485333 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.72912768 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72796525 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72442878 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71806830 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70290584 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70111715 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.69944986 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.67428008 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67155952 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66772109 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66436247 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66044975 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65747886 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.65722631 |
| 114 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64680250 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63278197 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62278221 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62118839 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61522457 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60880385 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59943257 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58685538 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58083986 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57957137 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56418449 |
| 125 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56192631 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56104236 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55974451 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55570187 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54910121 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54136878 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53761460 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53457194 |
| 133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52832554 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52005238 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51889129 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51655540 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50359251 |
| 138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49900133 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.49789125 |
| 140 | Influenza A_Homo sapiens_hsa05164 | 0.49484657 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49359400 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48905172 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48257096 |
| 144 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48178722 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47909407 |
| 146 | Lysine degradation_Homo sapiens_hsa00310 | 0.47740135 |
| 147 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47130418 |
| 148 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46732968 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46635209 |
| 150 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46306143 |
| 151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45991033 |
| 152 | Apoptosis_Homo sapiens_hsa04210 | 0.45934570 |
| 153 | RNA degradation_Homo sapiens_hsa03018 | 0.45795249 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45108612 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44866746 |
| 156 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44497240 |
| 157 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38167461 |
| 158 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36929686 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35766418 |
| 160 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33483587 |
| 161 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32186585 |
| 162 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29604944 |
| 163 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28230792 |
| 164 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27914703 |
| 165 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27183812 |
| 166 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27075134 |

